News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


HIV treatment takes two steps forward

Media release November 1, 2006

HIV treatment takes two steps forward

A once-a-day medicine to attack the HIV/AIDS virus is part of a package of treatments for people with HIV announced by Pharmac today.

Atazanavir (Reyataz) is a once a day HIV protease inhibitor which has the advantage of having fewer metabolic side effects than other protease inhibitor drugs. These side effects can can cause complications like heart disease.

The other part of the package is the listing of pravastatin (Pravachol), a cholesterol-lowering drug that can be used to correct metabolic side effects in people with HIV who are being treated with protease inhibitors. Two statins are already funded, atorvastain and simvastatin. However, pravastatin is the only one that can be used in combination with HIV protease inhibitors.

Both treatments will be funded from today (1 November 2006).

PHARMAC Medical Director Dr Peter Moodie says the two drugs provide the opportunity to advance treatment for HIV patients.

“By and large people can manage their HIV well with the drug treatments that are available,” Dr Moodie says. “It is not uncommon, though, for people who are taking protease inhibitors to have metabolic complications such as increased triglyceride and cholesterol levels. These can lead to an increased risk of heart disease so these funding decisions provide welcome new treatment options,” Dr Moodie says.

“Having a once-a-day protease inhibitor will mean that people who might find it difficult to take all their medicines in one day will have a better treatment option.”

Dr Moodie says the decision to subsidise atazanavir will benefit an estimated 40-50 people with HIV each year. About 30 people would benefit from pravastatin.

Atazanavir will join five other fully subsidised HIV protease inhibitors. Another treatment for HIV/AIDS, enfuvirtide, has also been funded recently.


ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

NZ On Air TV Funding: More Comedy Comes Out Of The Shadows

Paranormal Event Response Unit is a series conceived by Jemaine Clement and Taika Waititi as a TV spin-off from their highly acclaimed feature film What We Do In The Shadows. More>>

ALSO:

Mars News: Winners Announced For The 2016 Apra Silver Scroll Awards

Wellington singer-songwriter and internationally acclaimed musician Thomas Oliver has won the 2016 APRA Silver Scroll Award with his captivating love song ‘If I Move To Mars’. More>>

ALSO:

Scoop Review Of Books: Salt River Songs by Sam Hunt

Colin Hogg, a longtime comrade of Sam, writes in his Introduction that, ‘There is a lot of death in this collection of new poems by my friend Sam Hunt. It’s easier to count the poems here that don’t deal with the great destroyer than it is to point to the ones that do.’ More>>

Electronica: Restoring The World’s First Recorded Computer Music

University of Canterbury Distinguished Professor Jack Copeland and UC alumni and composer Jason Long have restored the earliest known recording of computer-generated music, created more than 65 years ago using programming techniques devised by Alan Turing. More>>

ALSO:

Scoop Review Of Books: Almost Getting Away With Murder

The Black Widow by Lee-Anne Cartier: Lee-Anne Cartier is the sister of the Christchurch man found to have been murdered by his wife, Helen Milner, after an initial assumption by police that his death, in 2009, was suicide. More>>

Howard Davis: Triple Echo - The Malevich/Reinhardt/Hotere Nexus

Howard Davis: The current juxtaposition of works by Ralph Hotere and Ad Reinhardt at Te Papa perfectly exemplifies Jean Michel Massing's preoccupation with the transmigration of imagery in a remarkable triple echo effect... More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news